Microfluidic devices
By combining portable computerized equipment with microscopy and electrochemical testing, the problems of immediacy and accuracy in disease diagnosis in remote areas have been solved, enabling rapid and accurate diagnosis and treatment, and supporting telemedicine analysis.
Patent Information
- Application Number
- CN202010741802.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-08-06
- Filing Date
- 2020-07-29
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2040-07-29
AI Technical Summary
Existing technologies make it difficult to achieve timely and accurate disease diagnosis in remote areas, especially due to the lack of microscopy equipment and trained experts. This leads to improper sample processing, long transportation times, and untimely results. Furthermore, rapid diagnostic tests (RDTs) suffer from insufficient sensitivity and specificity.
A portable computerized device has been developed that combines microscopy and electrochemical testing, providing instant diagnosis through microfluidic technology and biosensors. It is suitable for operators with minimal training and includes imaging and signal channels, supports the detection of a variety of diseases, and connects to mobile devices for remote analysis.
It enables instant and accurate disease diagnosis, reduces unnecessary drug use, facilitates rapid treatment, prevents the spread of disease, and supports real-time data tracking and telemedicine support.
Smart Images

Figure CN112337515B_ABST
Abstract
Description
[0001] Cross-citations of related applications
[0002] This application is a continuation-in-part of commonly owned PCT Patent Application No. PCT / IL2018 / 050132, filed on February 6, 2018, entitled: PORTABLE DIGITAL DIAGNOSTIC DEVICE, which is related to and claims priority to commonly owned U.S. Provisional Patent Application Serial No. 62 / 454,933, filed on February 6, 2017, entitled: PORTABLE DIGITAL DIAGNOSTIC DEVICE. The disclosure of each of the above patent applications is hereby incorporated by reference in its entirety. Technical Field
[0003] The present invention relates to a portable device for on-site disease diagnosis. Background Art
[0004] Many clinical trials require the collection of a blood sample to provide a diagnosis. Currently, the patient must give a blood sample on-site or off-site and then wait for test results because the blood sample must be taken to a laboratory for analysis, usually by trained personnel through a microscope. Even obtaining the blood sample must be done by trained personnel using multiple syringes, multiple butterfly needles, multiple blood tubes and other multiple blood collection devices. The multiple blood collection devices must be properly stored and kept sanitary to avoid contamination and thus unusability. In addition, once the blood sample arrives at the microscope, it must be properly "smeared" so that it can be used for microscopic or other analysis.
[0005] Microscopes are the "gold standard" for laboratory analysis. In more than 50% of the world, there are few clinics with access to microscopic equipment, as well as trained microscopists prepared to operate microscopic equipment and provide diagnosis of blood or tissue samples. Furthermore, obtaining test results from a microscope takes time, and is certainly not instant, even when the microscope is behind the scenes and the microscopist is on site, at a medical clinic, at a hospital, etc. Furthermore, in many parts of the world, trained microscopists and laboratories equipped with microscopic equipment suitable for microscopists are limited and may be located far from various populations, such as rural populations, adding additional difficulty to conducting blood tests whose results are determined by the microscope.
[0006] There are also problems associated with transporting blood samples to microscopy laboratories due to possible improper handling of the sample, as well as possible sample shedding due to weather and shipping time from the patient to the laboratory. Such blood tests are also expensive for many people around the world, making such tests inaccessible to many. Furthermore, because the results are not immediate and are often obtained off-site, patients may not be available for statistical studies, and infected patients requiring immediate treatment may not be located quickly enough.
[0007] Rapid diagnostic tests (RDTs) provide immediate results. However, there are no RDTs for many diseases, and detection of diseases does not have the significant sensitivity required for early detection and often has poor specificity. These RDT devices must be stored and handled properly to maintain accuracy and reliability. Furthermore, there are many manufacturers of RDTs, and the quality of said RDTs varies widely between manufacturers.
[0008] As diseases spread rapidly, it is extremely important to diagnose them quickly in the early stages. This ensures that said patients can be treated quickly, thereby keeping them healthy, and preventing the spread of the disease. In many places around the world, this is simply not possible due to a lack of laboratory facilities, coupled with a shortage of trained experts who can correctly identify the disease.
[0009] Furthermore, for some diseases, such as malaria, additional testing, such as testing for glucose-6-phosphate dehydrogenase (G6PD) deficiency, is required to determine the safest and most appropriate treatment (per the World Health Organization (WHO) guidelines for malaria elimination and eradication). Beyond malaria diagnosis, such testing is often unavailable and inappropriate for many rural and remote areas of the world. Summary of the invention
[0010] The present invention provides a computerized device that brings microscopy and electrochemical testing into the field, such as to perform on-site testing with real-time results instantly. This device can be operated by minimally trained operators, who can be community health workers, nurses, technicians, not just doctors.
[0011] These computerized devices are single handheld devices that can be taken to remote areas, enabling thousands of people to access healthcare that they did not have before. Because instant results are obtained, diseases and conditions are provided with certainty on the spot, eliminating unnecessary medication use (unnecessary administration of medications), such as unnecessary antibiotics and / or antimalarials. Additionally, because diseases and conditions can be detected immediately, treatment plans can be started immediately, eliminating the spread of infectious and deadly diseases and conditions.
[0012] The computerized device is a two-channel device, one channel for imaging or microscopy (optical), and one channel for electrochemistry (signaling). Based on the results from these two channels, a more accurate and effective diagnosis can be made on-site than is currently possible. This allows for rapid and safe treatment and tracking of diseases, inhibits the spread of diseases, and allows real-time mapping of patients to track the movement of diseases in real time and obtain other data for immediate and effective intervention by health authorities, research, etc. The device is, for example, a lab-on-hand computerized platform that can be programmed for a variety of medical diagnostic applications based on the same RevDx hardware platform.
[0013] The disclosed device allows for receiving a blood sample that can be collected by a user or medical personnel by pricking a finger with little or no training, and does not require trained medical personnel. The disclosed device is designed to be coupled to a mobile device or a mobile computer, such as a smart phone, wherein the device is designed to analyze the blood sample and provide an immediate diagnosis on-site and in real time. When each of the devices performs its analysis through techniques such as machine learning and other network connections such as telemedicine, wherein an image of the blood sample is transmitted to a trained medical personnel at a remote location via a network such as the internet.
[0014] By having this sensitive and accurate diagnosis immediately available, the patient can be treated more quickly, which can be done in a routine manner. This can protect the patient's health and, in the case of diseases that are contagious, prevent the spread of the disease.
[0015] The present invention uses a disposable sample preparation kit based on microfluidic technology and / or biosensor / electrochemical strips, and a corresponding reading and analysis system to diagnose different or dual-faceted diseases, usually on site. For example, for malaria, along with their reading and analysis, the microfluidic chip is able to detect malarial parasite types with high sensitivity and specificity, allowing malaria to be detected in the early stages when parasite density is low (compared to the late stages of malaria). The biosensor strips and reader channels are used to detect G6PD deficiency. This is necessary to ensure safe use of primaquine drugs for the treatment of malarial parasites Plasmodium vivax. In addition, primaquine is also used to prevent the spread of other malarial parasite types. The biosensor reader channel will also be used for glucose level monitoring. Since malaria can cause hypoglycemia (dangerously low levels of glucose), this will help decide which patients need to be hospitalized.
[0016] Furthermore, since both the microfluidic chips and biosensor strips are disposable and receive a blood sample at the time of testing, the process is sanitary because the disease cannot be transferred between patients being tested; the process is accurate because there is no possibility of blood splatter, and many patients can be tested in a very short time by minimally trained or untrained medical personnel. In addition, the plurality of microfluidic chips and the plurality of biosensor strips require a small amount of blood and can be used as a plurality of blood smears. For example, blood is obtained by pricking a finger, which can be performed by a user or someone with no or minimal medical training.
[0017] Furthermore, the method is inexpensive, since microfluidic chips and biosensor strips are inexpensive and the devices used are purchased once and can be used multiple times.
[0018] Embodiments of the present invention relate to an apparatus for analyzing a disease condition, the apparatus comprising: an imaging channel configured to provide a visual sample; and a signal channel comprising a signal analyzer for analyzing a plurality of received signals based on a plurality of electrochemical responses emitted from an electrode that has reacted to a sample to determine the presence of the disease condition.
[0019] Optionally, the device additionally comprises: an analysis module configured to scan an image of the visible sample and determine the presence of the disease condition from the scanned image.
[0020] Optionally, the analysis module is configured to determine from the scanned image the presence of the disease condition selected from the following group: G6PD deficiency output; blood glucose levels; malarial parasites, including P. falciparum, P. vivax, P. malaria, P. ovale, P. knowlesi; disease stage; complete blood cell counts; various parasites, including relapsing fever and Filarias; Tuberculosis; Pap smear analysis; urine test and / or analysis and veterinary diseases.
[0021] Optionally, the device additionally comprises: an optical mechanical system for magnifying and scanning the sample, wherein the optical mechanical system communicates with the analysis module.
[0022] Optionally, the device additionally comprises: a processor programmed to determine treatment for the disease condition, wherein the processor is in communication with the analysis module.
[0023] Optionally, the device additionally comprises: a processor programmed to determine treatment for the disease condition, the processor communicating with the analysis module and the signal analyzer.
[0024] Optionally, the imaging channel and the signal channel are configured to output a determination of the presence of the disease condition in real time.
[0025] Optionally, the device includes a display, which is in communication with the imaging channel and the signal channel.
[0026] Optionally, the display includes one or more of: (1) a screen display; and (2) a display output configured to communicate with an image sensor of an external computer device for displaying multiple graphics on the display screen of the external computer device.
[0027] Optionally, the imaging channel includes a first end for receiving the sample and an oppositely disposed second end associated with the display.
[0028] Optionally, the device additionally includes: an analog to digital signal converter (ADC) communicating with the signal analyzer; and a signal reader for reading the multiple electrochemical signals emitted from the electrodes that have reacted to the sample, wherein the signal reader communicates with the analog to digital signal converter.
[0029] Optionally, the signal analyzer is configured to analyze the signal to determine a disease condition selected from the following group: G6PD deficiency output; blood glucose level; malarial parasites, including Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and Plasmodium ovale; disease stage; complete blood cell count; multiple parasites, including relapsing fever and filariasis; tuberculosis; cervical smear analysis; and livestock diseases.
[0030] Optionally, the device additionally comprises: a processor programmed to transmit data to the display, which results in a graphical display of a user interface (UI) presenting the presence of the disease condition.
[0031] Optionally, the device additionally includes: a positioning module in communication with at least one of the imaging channel or the signal channel, the positioning module being configured to display a plurality of real-time location indications based on a global positioning system (GPS) mapping of the detection of the disease condition.
[0032] Optionally, the device additionally includes: a first port for accommodating a microfluidic chip that holds the sample so that the sample can be observed in the imaging channel; and a second port for accommodating an electrode that holds the sample in the signal channel.
[0033] Optionally, the device additionally comprises: a microfluidic chip for preparing a sample, to be accommodated in the first port.
[0034] Optionally, the device additionally comprises: a biosensor strip comprising an electrode for generating an electrochemical response when in contact with the sample, housed in the second port.
[0035] Optionally, the sample comprises multiple parts of the same sample, and the sample comprises at least one of blood, urine and tissue.
[0036] Optionally, the microfluidic chip is configured to mix the sample with one or more of a plurality of stains, a plurality of image enhancing agents, and a plurality of dilating agents.
[0037] Embodiments of the present invention are directed to a method for analysis, such as analysis of a disease condition, comprising providing a sample to an imaging channel of a device including a display for viewing on the display, and providing the sample to a signal channel of the device, the device including a signal analyzer, and the signal analyzer analyzing a plurality of received signals based on a plurality of electrochemical responses emitted from an electrode that has reacted to the sample to determine the presence of the disease condition.
[0038] Optionally, the method enables information about the disease state detected by the signal analyzer to be displayed on the display.
[0039] Optionally, the method is such that the sample provided to the imaging channel and the sample provided to the signal channel include multiple portions of the same sample, and the sample includes at least one of blood, urine and tissue.
[0040] Embodiments of the present invention relate to a microfluidic device, also referred to as a microfluidic chip or chip, comprising: a substrate including a first side and a second side disposed opposite to each other; a chamber extending from the first side to the second side into the substrate and to a base, the chamber including a protruding element, the protruding element forming a wall of the chamber; and a main channel extending along the base of the chamber and along at least a portion of the wall of the chamber.
[0041] Optionally, the microfluidic device is such that it additionally comprises: at least one channel extending from the main channel, the at least one channel being configured to align with an optical device of an apparatus of the substrate being viewed.
[0042] Optionally, the microfluidic device is such that: the chamber is conical, and the chamber gradually tapers inwardly from the first side to the second side.
[0043] Optionally, the microfluidic device is such that: the protruding element comprises a plurality of plates overlapping to form a wall of the chamber.
[0044] Optionally, the microfluidic device is such that: the plurality of plates are made of a flexible and elastic material.
[0045] Optionally, the microfluidic device is such that: the main channel is (elevationally) between the plurality of plates forming the wall and the base.
[0046] Optionally, the microfluidic device is such that: the main channel is C-shaped and conforms to the outer shape of the wall of the chamber.
[0047] Optionally, the microfluidic device is such that: the main channel includes an upper wall and a lower wall that are arranged opposite to each other, and an outer wall between the upper wall and the lower wall.
[0048] Optionally, the microfluidic device is such that: the main channel is such that the outer wall is substantially perpendicular to the upper wall and the lower wall which are arranged opposite to each other.
[0049] Optionally, the microfluidic device is such that: the dimensions of the main channel are designed to facilitate capillary action to move liquid through the main channel.
[0050] Optionally, the microfluidic device is such that: the first side comprises a surface, and the chamber extends from the surface into the substrate.
[0051] Optionally, the microfluidic device is such that at least one channel extending from the main channel is connected to the surrounding environment through an openable hole, so that the connection with the surrounding environment causes at least one channel extending from the main channel to be filled with liquid (fluid) from the main channel.
[0052] Throughout this document, references are made to directions such as up, down, top, bottom, inside, outside, and their derivatives. These directional references are exemplary only and are used to explain the disclosed subject matter in exemplary orientations, which are merely exemplary and in no way limiting.
[0053] Unless otherwise defined herein, all technical and / or scientific terms used in this article have the same meanings as those of ordinary skill in the art related to the present invention are generally understood. Although methods and materials similar or equivalent to those described herein can be used to practice or test embodiments of the present invention, exemplary methods and / or materials are described below. In the event of conflict, the present specification is the main one, including definitions. In addition, materials, methods and examples are illustrative only and are not intended to be limiting. BRIEF DESCRIPTION OF THE DRAWINGS
[0054] Some embodiments of the present invention are described herein with reference to the accompanying drawings by way of example only, wherein the same reference numerals or characters represent corresponding or similar elements. With specific reference now to the accompanying drawings, it is emphasized that the details shown are by way of example and for the purpose of illustrative discussion of embodiments of the present invention. In this regard, the description by the accompanying drawings makes it clear to those skilled in the art how to implement embodiments of the present invention.
[0055] Attention is now directed to the drawings, wherein like reference numerals or characters designate corresponding or similar parts. The drawings are as follows.
[0056] Figure 1 is a diagram illustrating an exemplary environment for executing various embodiments of the present invention;
[0057] Figure 2 is a block diagram of a base and computer device used in combination, and also shows how these devices are linked to a network;
[0058] Figure 3 is a schematic diagram of a base and a computer device used in combination;
[0059] Figure 4A is a flow chart of an exemplary process for the microscopy aspect of the present invention;
[0060] Figure 4B is a flow chart of an exemplary process of the electrochemical aspect of the present invention;
[0061] Figure 5A is a block diagram of a stand-alone computer device according to various embodiments of the present invention;
[0062] Figure 5B is a block diagram of another stand-alone computer device according to various embodiments of the present invention;
[0063] Figure 5C yes Figure 5B A perspective view of the device;
[0064] Figures 6A to 6D is a schematic representation of a microfluidic device for use in a plurality of the disclosed devices;
[0065] Figure 6E-1A and 6E-1B is a top perspective view of a microfluidic device for use in the disclosed apparatus;
[0066] Figure 6E-2 is a bottom view of a microfluidic device for use in the disclosed apparatus;
[0067] Figure 6E-3 is along Figure 6E-1B A cross-sectional view of a microfluidic device taken along line 6aa-6aa;
[0068] Figure 6E-4 is along Figure 6E-1B a cross-sectional view of a microfluidic device taken along line 6xx-6xx, accompanied by a detailed description;
[0069] Figure 6E-5 is along Figure 6E-1B A cross-sectional view of a microfluidic device taken along line 6yy-6yy, accompanied by a detailed description;
[0070] Figure 6E-6 Is taken from the bottom or second side Figure 6E-1A Photo of the microfluidic device;
[0071] Fig. 6F is a top view of a microfluidic device used in the disclosed apparatus;
[0072] Figure 6G is a top view of a circular microfluidic device for use in the disclosed apparatus;
[0073] Figure 7 is a flow chart of a process performed by the disclosed devices for determining malaria, and if detected, issuing a treatment plan; and
[0074] Figures 8A to 8D yes Figure 5B and 5C A plurality of screen images of a device while the device is running.
[0075] Detailed description with drawings
[0076] DETAILED DESCRIPTION Figure 1An example embodiment of the present invention is shown, in which an electronic device 100 in the form of a base (the electronic device 100 is also referred to as a base, and these terms are used interchangeably herein) accommodates a mobile computing device, such as a smart phone 102, including a display screen 103, in mechanical engagement so as to be directly linked to the optical device and to be in electronic and / or data communication with each other. The base 100 and smart phone 102 can also be linked to each other through multiple communication networks, such as a wide area or public network such as the Internet. It can also be linked through multiple near field communications and other electronic communication formats, and through a communication module 254 ( Figure 2 )'s input / output (I / O) ports.
[0077] The base 100 includes a port 110 for receiving a disposable sample preparation chip / box based on microfluidics 112, on which, for example, a blood sample is analyzed, and another port 114 for receiving a biosensor strip 116, which receives a blood sample at an operating end 116a, for example, on an electrode 116b. The ports 110 and 114 are associated with multiple channels. The port 110 is used as an inlet of a microscope, imaging channel or microscopic channel (the terms "imaging channel", "microscopic channel" and "optical / optical channel" are used interchangeably herein), for example, for malaria, identification of specific parasites (malaria types) and malaria stages and also complete blood count (Complete Blood Count; CBC) applications. Another port 114 is used as a signal channel or an electrochemical channel ("signal channel" and "electrochemical channel" are used interchangeably herein) for analyzing multiple electrochemical signals from a blood sample on the electrode 116b of the biosensor strip 116 and, for example, for use in malaria-infected patients to determine whether glucose-6-phosphate dehydrogenase (G6PD) deficiency is present to determine appropriate and precise drug treatment.
[0078] Figure 2 A block diagram of a base 100 and a smart phone 102 is shown. The base 100 and smart phone 102 are shown as being directly connected to each other and linked to one or more networks 200, such as a local area network (LAN), and a wide area network (WAN), including public networks such as the Internet, cellular networks, and other communication networks.
[0079] The imaging channel from port 110 and the signal channel from port 114 use a common central processing unit (CPU) 202, have linked storage / memory 204, a power source 206 for the base, and a communication module 208, wherein a male USB (Universal Serial Bus) connector 209 or other similar connector extends from the communication module 208.
[0080] The central processing unit (CPU) 202 is formed of one or more processors and is in electronic and data communication with a storage device / memory 204, which stores a plurality of machine executable instructions for execution by the CPU 202 to perform the dual channel processing. The power supply 206 is a battery or embedded power supply. In addition to providing a direct connection, the communication module 208 also provides network (e.g., Internet) connection and communication to the base 100 for electronic and data communication between the base 100 and the smart phone 102.
[0081] The imaging channel includes the port 110, which accommodates a microfluidic chip 112 ( Figure 1 ), also known as a microfluidic device. The microfluidic chip 112 is connected to the optical device 308 ( Figure 3 ) can be seen, including an optical mechanical system 212 and an optical relay system 214, and terminated in an optical module lens 216, wherein the image is transmitted through the optical module lens 216. The optical device 308, such as the optical mechanical system 212, magnifies the sample and enhances the visual presentation including multiple images so that its micron high resolution can be achieved.
[0082] The microfluidic chip 112 operates based on capillary action to transport the received blood and stain it so that it can be properly observed. An optical mechanical system 212 (having a controller 212a) provides scanning of the microfluidic chip 112 through an optical relay system 214 for scanning the microfluidic chip 112 (by the controller 212a in the scanning mechanism 304 ( Figure 3 ) provided by the movement of a rack / drawer 302 on the optical module 214), the optical relay system 214 terminates at the optical module lens 216. There is also a light (LT) 217 as part of the optical mechanical system 212, which can be manually controlled (via switches, buttons, etc. (not shown)) or controlled by the controller 212a. The optical mechanical system 212 and the optical relay system 214 are in electronic and / or data communication with the CPU 202, the storage device / memory 204, the power supply 206 and the communication module 208 directly or indirectly.
[0083] Figures 6A-6G Various microfluidic chips (microfluidic devices) 112a to 112g are shown, which are embodiments of the microfluidic chip 112. These microfluidic chips 112a to 112g are received in the port 110 of the disclosed apparatus (device) 100, 500, 500'. Figures 6A to 6G The microfluidic chips 112a to 112g shown in the drawings include substrates 601, 664 made of, for example, glass or polymer or both or other materials with / without a hydrophilic coating, which are suitable for supporting blood and / or other fluids (liquids), such as urine, and may also include other components, such as stains for microscopy, and other substances (solid, liquid or gas), such as powders from fragile capsules. The aforementioned fluids (liquids) and / or fluids (liquids) mixed with other components are analyzed and / or displayed by the disclosed apparatus (device) 100, 500, 500'.
[0084] Fig. 6A The microfluidic chip 112a shown in includes a substrate 601, which is glass or polymer or both or other materials with / without hydrophilic coating, suitable for supporting blood and / or other fluids (liquids), such as urine, and may also include other components, such as staining (stain) for microscopic examination, and other substances (solid, liquid or gas), such as powder from fragile capsules. On the substrate 601 is a blood inlet 602, and a dye wrapped in a blister (packaging) 604 is located at one end 601a of the substrate 601. When it is needed to use, the pressure on the blister 604 causes the blister 604 to break from the tunnel side and press the dye through the microfluidic tunnel 606. The blood and / or diluted blood and dye travel to a serpentine microfluidic channel 608 by means of microfluidic channel 606, and the serpentine microfluidic channel 608 is used as a mixing area 610 of blood and dye. The still moving blood and stain combination passes through another microfluidic channel 612 to an observation chamber 614 at the opposite end 601b of the substrate. The observation area 614 is configured on the substrate 601 to align with the optics 308 of the optomechanical system 212 of the device 100,500.
[0085] Figure 6BThe microfluidic chip 112b shown in the figure includes a substrate 601 for supporting blood and other components, such as dyeing, washing solutions, for microscopy. On the substrate 601 is a blood inlet 622, a dye wrapped in a blister (package) 624, and a cleaning solution wrapped in a blister (package) 626 at one end of the substrate 601a. When needed, blood from the blood inlet 622 flows through the microfluidic channel 628, leaving blood cells adhered to the wall of the microfluidic channel 628. The pressure on the blister 624 causes the blister 624 to rupture, causing the dye to flow through the microfluidic channel 628 above the adhered blood cells, so that the dye and cells reach the dyeing and observation area 630 on the substrate 601. The dyeing and observation area 630 is configured on the substrate 601 to align with the optical device 308 of the optical mechanical system 212 of the device 100, 500. Next, pressure on the bubble 626 ruptures the bubble 626, allowing a wash solution to flow through the microfluidic channel 628, removing any residual stain and diluting the blood-stain mixture.
[0086] Figure 6C The microfluidic chip 112c shown in the figure includes a substrate 601 for supporting blood and other components, such as stains, for microscopic examination. On the substrate 601 is a blood inlet 642 (at one end 601a of the substrate 601), which is located at one end of a microfluidic channel 644, which terminates in a staining and observation chamber 646 (at the other end 601b of the substrate 601). The staining and observation chamber 646 is configured on the substrate 601 to align with the optical device 308 of the optical mechanical system 212 of the device 100, 500. The stain in a dry state is contained in the walls of the microfluidic channel 644 so that when blood or diluted blood 647 flows through the microfluidic channel 644 to reach the staining and observation area, the blood 647 absorbs the stain. This microfluidic chip 112 is generally used to observe single red blood cells. Here, the microfluidic channel is shallow, about 10 microns in diameter, because the blood is not diluted.
[0087] Fig.6DThe microfluidic chip 112d shown in the figure includes a substrate 601 for supporting blood and other components. The substrate 601 supports a sample inlet 652 at one end 601a, and the sample inlet 652 is connected to a microfluidic channel 654, which is in turn connected to and terminates at an observation chamber 656 at the other end 601b of the substrate 601. A blood sample that is diluted or undiluted is mixed with a dye 657 and placed in the sample inlet 652, wherein the dyed sample flows to the observation area 656. The observation chamber 656 is configured on the substrate 601 to align with the optical device 308 of the optical mechanical system 212 of the device 100, 500.
[0088] Now turn your attention to Figure 6E-1A , 6E-1B, 6E-2, 6E-3, 6E-4, 6E-5 and 6E-6 ( Figures 6E-1A to 6E-6 ), which shows another microfluidic chip 112e for use with the device 100, 500, 500'. The mixing chamber 662 extends from a first side 666a (e.g., the upper (top) side of the upper surface 666ax) to the substrate (body) 664 and to the base 668. The base 668 is partially surrounded by the main channel 670 at the second side 666b (e.g., the lower (bottom) side). The base 668 is an extension of the mixing chamber 662 and serves as a pressure balancing container, for example, for collecting excess blood-staining agent mixture. The base 668x is surrounded by the main channel 670 and together serves as a connecting vessel during blood-staining agent mixing. The main channel 670 is generally U-shaped, having a main C-shaped portion 670a extending outwardly from a portion 670b, which forms the starting point of the channel 670 and serves as, for example, a receiving area for blood and other fluids. The first side 666a and the second side 666b are, for example, arranged opposite to each other.
[0089] Inlet / outlet channels 672, terminating in holes 673, each extend from a respective extension 670b of the main channel 670. In operation, blood / fluid is inserted from the holes 673 through the channels 672 where the blood / fluid fills the main channel 670 driven by capillary forces.
[0090] The scanning channel 674 is configured to be aligned with the optics 308 of the optomechanical system of the corresponding device 100, 500, 500', extending from the main channel 670 through the substrate 664 to the pressure outlet channel 676. The scanning channel 674 is oriented, for example, substantially perpendicular to or perpendicular to the pressure outlet channel 676. The pressure outlet channel 676 terminates at a hole 678, which is initially sealed (closed). In operation, when the hole 678 is pierced so as to be opened to the surrounding environment at, for example, ambient pressure, an air inlet / outlet is created, allowing blood (or fluid) and / or a stained mixture of blood (or fluid) (which may also include other substances, such as substances from a frangible capsule, as described in detail below) to fill the scanning channel 674.
[0091] The mixing chamber 662 extends into the base 664 in the form of a truncated cone that tapers inwardly (from the first side 666a to the second side 666b), for example, it can also be rounded, substantially circular or circular, but other shapes that taper inwardly can also be included. The wall 680 of the mixing chamber 662 is formed by overlapping (staggered) plates 682 or protruding elements. When an element such as a breakable or crushable capsule is placed in the mixing chamber 662, the plates 682 provide traction for mixing.
[0092] Wall 680 extends inwardly into base plate 664 such that plate 682 terminates in main channel 670 at first or upper wall 684 of main channel 670. Main channel 670 also includes outer wall 685 connected to base 668 (base 668 forms a third or lower wall of channel 670, with third wall 668 disposed opposite first wall 684). Outer wall 685 is substantially perpendicular or perpendicular to first wall 684 and base 668 such that main channel 670 is open along one side, as shown in FIG. Figure 6E-4 and 6E-5 As shown. The configuration of the three walls 684 (first or upper wall), 685 (second or outer wall), 668 (third or lower wall) allows the main channel 670 to retain blood and / or other liquids by capillary action and / or surface tension. Similarly, the scanning channel 674 is also used to promote the movement of blood / liquid thereon by capillary action.
[0093] The base plate 664 is made of a plastic material so that it is optically translucent and, for example, transparent. The plate 682 (forming the chamber wall 680) is made of an elastic material, which is, for example, flexible and elastic. All of the above materials can be sterilized by heating or the like.
[0094] Figure 6E-6is a photograph of the second side 666b of the microfluidic chip 112e, showing that the main channel 670 has been filled with blood and / or fluid (which may also include dye and / or other substances) via capillary action.
[0095] Fig. 6F Another embodiment of a microfluidic chip 112f including a substrate 664 is shown. This microfluidic chip 112f is similar in construction to Figure 6E-1A to Figure 6E-6 Chip 112e. Figure 6E-1A to Figure 6E-6 , unless otherwise specified, the corresponding structure has the same element number and description as described above for the microfluidic chip 112e. This microfluidic chip 112f includes two mixing chambers 662 and a channel structure, as described above for the microfluidic chip 112e, but with the addition of a fluid inlet 686. The fluid (liquid) inlet 686 is in fluid communication with reference channels 688 and 688a, which lead to the main channel 670 of each mixing chamber 662. The scanning channel 674 is configured to align with the optical device 308 of the optical mechanical system of the corresponding device 100, 500, 500'. According to the detailed description for the microfluidic chip 112e, the scanning channel 674 terminates in a pressure channel (not shown), which terminates in a hole 678.
[0096] Figure 6G Another embodiment of a circular microfluidic chip 112g is shown. Unless otherwise specified, for each microfluidic chip 112e, 112f, the elements similar to microfluidic chips 112e, 112f have the same element number, and for the corresponding microfluidic chips 112e, 112f, operate according to the description provided above. Microfluidic chip 112g is formed by substrate 664 and has two mixing chambers 662, which are covered on main channel 690, and main channel 690 is similar to main channel 670 because they are U-shaped with outward extension. Blood / fluid is received in fluid inlet 692, which is in fluid communication with reference channel 693, and this reference channel 693 is in fluid communication with main channel 690 of each mixing chamber 662. Test channel 694 (also a reference channel) is in communication with corresponding reference channel 693.
[0097] The main channel 690 is in fluid communication with the scanning channel 696 and extends from the mixing chamber 662. The scanning channel 696 is then rounded and has a rounded portion 696a, which is formed based on the round shape of the microfluidic chip 112g and the substrate 664. The scanning channel 696 (including the portion 696a) is configured to align with the optical device of the optical mechanical system of the corresponding device. The pressure outlet channel 698 extends from the scanning channel 696 at the rounded portion 696a. The pressure outlet channel 698 is oriented, for example, to be substantially perpendicular to or perpendicular to the scanning channel 696. Each pressure outlet channel 698 terminates in a hole 699, which is sealed until opened, as detailed in the hole 678 above.
[0098] Back to Figures 6E-1A to 6E-6 With microfluidic chip 112e, example operation is now described. Microfluidic chips 112f, 112g operate similarly, and the description of the operation of microfluidic chip 112e is applicable to these microfluidic chips 112f, 112g. Initially, blood or other fluid (blood for which example operation is described hereinafter) is obtained and placed into main channel 670 (fluid inlet 686 of microfluidic chip 112f and fluid inlet 692 of microfluidic chip 112g). Once entering main channel 670, blood fills main channel 670 and flows therein by capillary action.
[0099] A breakable capsule or other substance is placed into the mixing chamber 662, for example by crushing it by applying pressure on the mixing chamber 662. The encapsulated reagent mixes with the blood in the main channel 670. The holes 678 of each pressure outlet channel 676 are opened so as to be at ambient pressure, allowing the mixed blood / substance to flow to fill the scanning channel 674 for observation and analysis by the optical elements of the device (apparatus) 100, 500, 500'.
[0100] The signal path starts at the port 114 and includes a biosensor strip reader 222 that reads the electrical response (current generated from the electrochemical reaction between the sample and the electrode 116b, output from the electrode 116b / biosensor strip 116 as an analog signal) from the disposable biosensor electrode 116b (e.g., at the operating end 116a of the biosensor strip 116) and amplifies the analog signal of the electrical response, the analog signal being indicative of the electrochemical reaction for disease, condition, measurement, etc. There is an analog-to-digital converter (ADC) 224 that converts the analog signal from the reader 222 into a digital signal. There is a signal analysis software module 226 that analyzes multiple digital signals to determine whether G6PD deficiency is present in the sample and communicates with the communication module 208 to send the multiple signals to the smart phone 102 for additional analysis.
[0101] Alternatively, the signal channel can be used for blood glucose level detection. The biosensor strip reader 222 is also configured to amplify (multiple) analog signals generated by the electrical response from the disposable biosensor electrode (e.g., the biosensor strip 116). The multiple analog signals correspond to blood glucose levels. The analog-to-digital converter (ADC) 224 converts the analog signals from the reader 222 into digital signals, and a signal analysis module 226 analyzes the digital signals received from the ADC 224 to determine the blood glucose level in the blood sample. The blood glucose level is output to the communication module 208 based on a standard measurement value of blood glucose, and the multiple signals are sent to the smart phone 102 for additional analysis and for use in (the smart phone 102 or the stand-alone device 500, 500') Figure 5A and 5B )) is shown on the display.
[0102] Alternatively, the plurality of biosensor strips 116 may include a plurality of biosensor electrodes 116b, including electrodes for generating an electrical response that can be converted into a readable signal for concurrently detecting G6PD deficiency and blood glucose levels, and for example, simultaneously.
[0103] In other alternatives, the signal channel can be used for other conditions, such as other diseases, pathogens or biomarkers. The biosensor strip reader 222 is also configured to amplify or otherwise modify multiple analog signals generated by the electrical response (electrochemical response) from the electrodes on the disposable biosensor strip. The electrodes on the biosensor strip are configured to produce an electrochemical reaction when a sample comes into contact with the condition, the electrochemical reaction being the current and corresponding analog signal generated by the condition (the biosensor strip reader is configured to identify the electrochemical characteristics (or electrochemical response) of these conditions and amplify the resulting analog signal caused by the electrochemical response). The analog-to-digital converter (ADC) 224 converts the analog signal from the reader 222 into a digital signal, and a signal analysis module 226 (programmed to determine the condition, for example, presence or absence) analyzes the multiple digital signals received from the ADC 224 to determine the condition. The disease judgment is output to the communication module 208 to send the judgment signal to the smart phone 102 so that (the smart phone 102 or the independent device 500, 500'( Figure 5A and 5B ) is presented on the display screen.
[0104] The device, for example, the smartphone 102 includes portions of both the microscope channel and the signal channel. The smartphone 102 includes a common central processing unit (CPU) 242 with linked storage / memory 244, a screen display module 246 including logic for controlling the screen display 103 of the smartphone 102, a global positioning system (GPS) module 248, data storage 250, such as RAM (random access memory), sensors 252, such as gyroscopes, temperature, magnetometers and accelerometers, forming the internal measurement unit (IMU), and a communication module 254 including a female USB (Universal Serial Bus) connector 255 or other similar connector for accommodating the male connector 209 in electronic and / or data communications. The GPS or positioning module 248 is used to provide display of real-time location indication by mapping diseases based on an incorporated GPS unit (of the smart phone 102 or as part of a standalone device GPS or positioning module 548) for real-time mapping and epidemiological control and study of diseases such as malaria.
[0105] There is also a camera / image sensor unit 260 for converting the camera image into a plurality of signals for display on the screen display 103 (via the screen display module 246). There is also an analysis module 264 for image analysis to detect, for example, the type of malarial parasite (e.g., P. falciparum, P. vivax, P. malaria, P. ovale, P. knowlesi and disease stage) and to mark data associated with a particular blood sample. Alternatively, the analysis module 264 can be programmed to analyze and detect other diseases and conditions, including complete blood counts, various parasites (e.g., relapsing fever, filariasis), tuberculosis, microscopy, urine analysis, Pap smear analysis, etc., as well as livestock diseases and conditions.
[0106] Both the base 100 and the smartphone 102 are linked to a cloud server 270 via the network(s) 200, where each frame sample of malaria parasites is sent (directly or from the data store 250) to the cloud server 270 for cumulatively updating the machine learning of the analysis module 264. With each new image frame sample, the cloud server 270 sends updated machine learning to the analysis module 264 so that it can better detect malaria parasites. This can be done online or offline, automatically or on request, whenever a connection is available. The cloud server 270 also stores each test record collected, time, location, diagnosis (both parasites and G6PD), patient information and symptoms, etc., for example by the machine 102 and optionally the diagnosis, screen display and other information from the telemedicine provider 280, and the cloud server 270 can map malaria cases in real time. All data storage and data transmission over the network(s) 200 between any of the base 100, smart phone 102, cloud server 270, telemedicine provider computers 280a, 280b is compliant with HIPAA (Health Insurance Portability and Accountability Act).
[0107] For example, the base 100 and smartphone 102 are also linked to a remote medical provider 280 via the network(s) 200 through a computer 280a or smartphone 280b (via a cellular tower 282). The remote medical provider 280 can provide a diagnosis that is sent to the cloud server 270 or back to the analysis module of the smartphone 102.
[0108] Figure 3 A schematic diagram of the imaging channel and the signal channel is shown. These channels are located in the base 100 and the smart phone 102 respectively.
[0109] The microscope channel begins at the port 110, which receives a microfluidic chip 112. The chip 112 uses capillary action to distribute the blood sample and appropriately stain and separate the plurality of blood cells. The optical mechanical system 212 includes a rack or a drawer 302 that supports the microfluidic chip 112. The rack / drawer 302 is located on a scanning mechanism 304 controlled by a controller 212a, which allows the chip 112 to be manipulated into various positions (indicated by double-headed oval arrows 306) for viewing through the optics 308 of the optical relay system 214, which terminates in a lens 216, etc. The screening mechanism (formed by the rack / drawer 302 and the scanning mechanism 304) is, for example, based on the movement or optical shielding of the drawer 302; for example, based on optical design, such as the use of mirrors or prisms (which are part of the optical relay system 214).
[0110] The image from the optical device 308 of the optical relay system 214 (including a light 309 (similar to the light 217 detailed above)) is sent to the multiple lenses 320 of the camera 260 of the smart phone 102 or, in the case of a separate device, to a separate image sensor. The image from the camera 260 is converted into a signal by the image sensor unit 262, and a plurality of output signals are input to the analysis module 264. The plurality of output signals are also transmitted from the analysis module 264 to the screen display module 246, so that the blood sample is displayed on the display screen 103.
[0111] The analysis module 264 is trained by multiple processes including image analysis, machine learning and artificial intelligence (AI) to determine the disease or condition and provide a diagnosis and / or treatment plan for the detected disease or condition. Moreover, the CPU 202 is used to provide a diagnosis and / or treatment plan for the detected disease or condition. The detection and / or diagnosis of such diseases and / or conditions is, for example, based on morphological "biomarker" analysis of parasites in their different stages and types. The algorithm (executed by the controller 212a) includes image processing capabilities (in software and / or hardware), segmentation capabilities (in software and / or hardware), filters and comparisons with specific morphologies of known and collected data from the RevDx system. The resulting diagnostic data is stored in the data storage 250 and / or in the cloud server 270. For example, it is also sent to a remote medical provider 280 for confirmation.
[0112] The signal path starts at the port 114. A blood sample on a biosensor strip 116 is placed into the port 114, and an electrical response (electrochemical response) is generated from the electrochemical reaction, which produces a plurality of analog signals of interest. The plurality of analog signals are read by the biosensor reader 222, which amplifies the analog signals of interest. The biosensor reader 222 amplifies and in some cases filters the analog signals, which are converted to digital signals by an analog-to-digital converter (ADC) 224. The ADC 224 output of the (multiple) digital signals is input into the signal analysis module 226, which analyzes the digital signal input, for example, for G6PD deficiency. Data corresponding to the G6PD present in the sample is sent by the signal analysis module 226 to the communication module 208, and then to the communication module 254 of the smartphone. Now in the smartphone, the data goes from the communication module 254 to the analysis module 264, where a recommended medication is analyzed based on a known course of treatment. The analysis module 264 signals the screen display module 246 to display a graph on the display screen 103 listing whether G6PD deficiency is present and the type of malarial parasite, what species, its density, stage and other factors.
[0113] Alternatively, if the signal channel is configured to provide a blood glucose reading, such a blood glucose reading may be obtained using or separately from the G6PD output, depending on the electrode(s) 116b on the biosensor strip 116, as described above. For example, the results of G6PD may be analyzed by the CPU 202 in combination with a glucose level to determine a treatment plan, such as, for example, Figure 7 The plurality of treatment options and the presence of a disease or condition are displayed as a user interface (UI) on a display screen, smart phone or stand-alone device 500, 500' as directed by the CPU 202 in the disclosed apparatus 100, 500, 500'.
[0114] If malaria is detected, the final decision on the malaria treatment plan is based on the analysis of both the microscopy channel and the signal channel. The analysis is automatically performed on-site within a few minutes by an algorithm (e.g., run by the CPU 202), or in the case of uncertainty, the data can be sent over the Internet and analyzed remotely by a telemedicine provider 280 through multiple networks 200.
[0115] Likewise, if the signal channel is configured to provide other readings of diseases and conditions in the blood, including G6PD output, blood glucose or urine testing, for example, the CPU 202 may be programmed to analyze one or more of the foregoing together to determine a treatment plan.
[0116] Now turn your attention to Figure 4A and 4B , which shows a flowchart detailing a computer-implemented process according to an embodiment of the disclosed subject matter. Figures 1 to 3 The components shown in . Figure 4A and 4B The process and the plurality of sub-processes are computerized processes performed by the system of the present invention, and are, for example, performed manually, automatically, or a combination thereof, and are, for example, performed in real time.
[0117] Figure 4A 4 is a flow chart of an example of a microscopy method of the microscope channel of the present invention. Initially, a blood sample is obtained and placed on a microfluidic chip, such as the microfluidic chip 112 described in detail above, and the blood is stained at box 402, wherein the microfluidic chip 112 is placed in the base 100 by means of the port 110. At box 404, with the help of the optical relay system (optical relay) 214, the microscopic image of the blood sample stained in the microfluidic chip reaches the camera 260 of the smart phone or in the independent device concept 102. At box 406, the image in the camera / image sensor unit 260 is converted into digital data, such as a plurality of digital signals. At box 408, the digital data is analyzed by the software analysis module 264 using machine learning and artificial intelligence (AI). At box 420, the analysis module 264 reports a diagnosis. In addition, at box 420, the image of the blood sample is displayed on the screen display 103 by means of the screen display module 246. From block 408, the process may move to block 470 where it ends.
[0118] Moving from block 420 to block 430, the analysis module 264 optionally labels the data of the blood sample including the visual image.
[0119] From block 430 , the process may move one or more of three alternative paths, defined by the blocks in series 440 , series 450 , and series 460 .
[0120] Moving from block 430 to block 440, the labeled sample data may be stored, for example, in data storage 250. Then, at block 442, the labeled data may be sent from storage to a cloud server, such as cloud server 270, or from block 430 to block 442, directly to cloud server 270. At block 442, in cloud server 470, its machine learning, artificial intelligence (AI) is updated with the data and diagnosis for the image. The process moves to block 444, where the analysis module 264 is updated with the new data. The process then moves to block 470, where it ends.
[0121] Moving from block 430 to block 450, the labeled sample data or stored labeled sample data (from block 440) may be sent in an optional process, for example, via network(s) 200 to a remote medical professional 280, for example, to his computer 280a or smartphone, tablet, notebook 280b, etc. At block 452, a diagnosis is received from the remote medical provider 280, for example, at smartphone 102, from where it moves to block 470 where it ends, or in a cloud server 270. Once received in the cloud server 270, the process then moves to block 444, where the analysis module 264 is updated with this new data, or to block 460, as described in more detail below. From block 444, the process moves to block 470, where it ends.
[0122] At block 460, which arrives from block 430 or block 452, the sample based on the GPS tag and time stamp can be optionally mapped, for example, by the cloud server 270. The process can move to an optional process at block 462, where the cloud server 270 provides a map of all test results. The process then moves to block 470, where it ends. The process can also move from block 460 to block 470, where it ends.
[0123] Figure 4B 4 is a flow chart of an exemplary signal processing process of the signal channel of the present invention. Initially, at box 412, a blood sample is obtained and placed on a biosensor strip, such as the biosensor strip 116 described in detail above. At box 402, the biosensor strip 116 is placed into the base 100 through port 114. The blood sample causes an electrochemical reaction, resulting in an electrical response being output as (multiple) analog signals at box 414, wherein the biosensor reader 222 reads the output analog signals. For example, the analog signal output is amplified by the biosensor reader 222 and input into an analog-to-digital converter (ADC) 224 at box 416, which converts the multiple analog signals into multiple digital signals. Then, at box 418, the multiple digital signals are input into a signal analysis module 226, where the signals are analyzed. Then, at box 420', the multiple signals are passed to the analysis module 264, which reports a diagnosis. Additionally, at block 420', a graphic and absolute number indicative of G6PD deficiency are displayed on the screen display 103 via the screen display module 246. From block 418, the process may move to block 470 where it ends.
[0124] From block 420', the process may move to an optional process at blocks 430, 440, 442, 444, 450, 452, 460, or 462 and ultimately end at block 470, as described above.
[0125] Figure 5A and 5B Alternative mobile computing devices 500 and 500' are shown for performing the disclosed process through a microscope channel and a signal channel. The devices 500, 500' include components that are the same or similar to those in the device 100 and have the same element numbers, and the devices 500, 500' are similar to those described above for Figure 2 The components are consistent with the components described in the device 100 of FIG. The multiple components include: a screen display module 546 (which controls the screen display 503, such as a touch screen of the device 500); a positioning-based GPS module 548; a data storage 550; multiple sensors IMU 552; an image sensor unit 562 and an analysis module 564, wherein the multiple components are consistent with Figure 2 The components are the same or similar to the corresponding components on the smart phone 102, but the components have a component number of 500 (rather than Figure 2 200 in , and with Figure 2 The analysis module 564 analyzes the scanned sample, for example, by image recognition, artificial intelligence, etc., to determine the presence or absence of disease and / or condition (e.g., diagnosis of malaria parasites) or measurement (e.g., blood glucose level and complete blood cell count). The optical relay system 214 is optional because the device 500 ( Figure 5A ) can work as a standalone device, where the lens 216 and optical relay system 214 are not required, or work with a smartphone or other device, where the optical relay system 214 and lens 216 may be required. The device 500 '( Figure 5B ) lacks the optical relay system 214 and lens 216 and therefore operates exclusively as a stand-alone device.
[0126] Figure 5C The device 500' is shown as a standalone unit, comprising a screen display 503 presenting a screen shot 580. The device 500' is handheld and therefore portable, battery operated, and optionally rechargeable from an external power source and solar energy.
[0127] Figure 7A process as a decision diagram is shown, for example, programmed into (and executed by) the CPU 202 of the devices 100, 500, and 500' for treatment decision support (e.g., providing multiple treatment recommendations, multiple treatment plans, etc.). The multiple treatment recommendations and multiple plans appear, for example, as a user interface (UI) on a screen display, such as a user interface (UI) on the screen display 503 of the stand-alone device 500', as shown in FIG. Figures 8A to 8D The multiple screen displays (multiple screen shots) 580a to 580d are shown in and are described in detail below.
[0128] In the first branch of the process, at box 702, if falciparum malaria is detected. At box 704, a glucose check is performed to see if the subject is hypoglycemic. At box 706, if yes, treatment with artemisinin combination therapy (ACT) is recommended. At box 708, if primaquine is used to prevent further transmission, a G6PD deficiency test can be performed before treatment using the device 100, 500, 500' disclosed herein.
[0129] In the second branch of the process, at box 712, if non-falciparum malaria or mixed infection is detected, treatment is recommended at box 714 using the device 100, 500, 500' disclosed herein, with ACT or chloroquine and G6PD testing. If G6PD is negative, treatment with primaquine is recommended at box 716.
[0130] In the third branch of the process, at box 722, if there is a negative test for both falciparum and non-falciparum malaria, and if the patient has a high clinical suspicion, testing with the apparatus 100, 500, 500' disclosed above is recommended.
[0131] Fig. 8A Device 500' is shown with screenshot 580a showing the results of a malaria test and suggesting a treatment plan. Figure 8B Device 500 ′ is shown with screenshot 580 b showing the results of a malaria test and providing information about medications, which may come from CPU 202 or cloud server 270 . Figure 8C Device 500' is shown with screenshot 580c detailing a white blood cell count. Fig.8D Device 500' is shown with screenshot 580d detailing a red blood cell count.
[0132] While the devices and methods disclosed above relate to diseases, such as malaria, the devices are also applicable to diagnosing other disease conditions and blood cell counts, such as white / red blood cell counts and white blood cell differentiation, where various modules are programmed to identify white / red blood cells and their analysis.
[0133] The implementation of the method and / or system of multiple embodiments of the present invention may involve performing or completing selected tasks manually, automatically, or a combination thereof. In addition, actual instruments and devices according to embodiments of the method and / or system of the present invention may implement several selected tasks through a combination of hardware, software, or firmware or using an operating system.
[0134] For example, the hardware for performing the selected tasks according to the embodiments of the present invention can be implemented as a chip or circuit. For software, the selected tasks according to the embodiments of the present invention can be implemented as multiple software instructions executed by a computer using any appropriate operating system. In an exemplary embodiment of the present invention, one or more tasks according to the exemplary embodiments of the method and / or system described herein are performed by a data processor, such as a computer platform for executing multiple instructions. Optionally, the data processor includes a volatile memory and / or non-volatile memory for storing instructions and / or data, for example, a magnetic hard disk and / or removable media for storing instructions and / or data. Optionally, a network connection is also provided. Optionally, a display and / or user input device such as a keyboard, mouse or printer is also provided.
[0135] For example, any combination of one or more non-temporary computer-readable (storage) media can be used according to the above-listed embodiments of the present invention. The non-temporary computer-readable (storage) medium can be a computer-readable signal medium or a computer-readable storage medium. A computer-readable storage medium can be an electronic, magnetic, optical, electromagnetic, infrared, or semiconductor system, device or equipment, or any combination of the above, but is not limited to this. More specific examples (non-exhaustive list) of computer-readable storage media include the following: an electrical connection with one or more wires, a portable computer disk, a hard disk, a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM or flash memory), an optical fiber, a portable compact disk read-only memory (CD-ROM), an optical storage device, a magnetic storage device, or any combination of the above. In this article, a computer-readable storage medium can be any tangible medium containing or storing a program, which can be used by an instruction execution system, device or device, or is related to an instruction execution system, device or device.
[0136] A computer readable signal medium may include a propagated data signal with computer readable program code embedded therein, for example, in baseband or as part of a carrier wave. Propagated data signals such as these may take any of a variety of forms, including, but not limited to, electromagnetic, optical, or any suitable combination. A computer readable signal medium may be any computer readable medium that is not a computer readable storage medium, which is capable of communicating, propagating, or transmitting a program that may be used by or in connection with an instruction execution system, apparatus, or device.
[0137] In conjunction with the paragraphs and drawings provided above, it will be possible to understand the various embodiments of the computer-implemented methods provided herein, wherein some embodiments may be implemented by the devices and systems described herein, and some embodiments may be implemented according to instructions stored in the non-temporary computer-readable storage medium described herein. However, some embodiments of the computer-implemented methods provided herein are implemented by other devices or systems and are implemented according to instructions stored in a computer-readable storage medium not described above. This will become clearer to those skilled in the art when combined with reference to the embodiments described herein. Any reference to the system and computer-readable storage medium of the following computer-implemented methods is provided for the purpose of explanation and is not intended to limit any such system and such non-temporary computer-readable storage medium of the embodiments of the above-mentioned computer-implemented methods. Similarly, any reference to the following computer-implemented methods of the system and computer-readable storage medium is provided for the purpose of explanation and is not intended to limit any such computer-implemented methods disclosed herein.
[0138] The flowcharts and block diagrams in the accompanying drawings show the operations, methods and computer program products that may be implemented by the architecture, functions and systems according to multiple embodiments of the present invention. In this regard, each box in the flowchart or block diagram may represent a module, segment or part of a code, and the module, segment or part of the code contains one or more executable instructions for implementing the specified logical functions. It should also be noted that in some alternative embodiments, the functions marked in the box may also occur in an order different from that marked in the accompanying drawings. For example, two consecutive boxes can actually be executed substantially in parallel, and they may sometimes be executed in the opposite order, depending on the functions involved. It should also be noted that each box in the block diagram and / or flowchart, as well as the box combination in the block diagram and / or flowchart, can be implemented with a dedicated hardware-based system that performs the specified function or action, or can be implemented with a combination of dedicated hardware and computer instructions.
[0139] Descriptions of various embodiments of the present invention have been provided for purposes of illustration, but are not intended to be exhaustive or to limit the invention to the forms disclosed herein. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the embodiments described herein. The terminology used herein is selected to best explain the principles of the embodiments, practical applications or technical improvements over technologies found on the market, or to enable others skilled in the art to understand the embodiments disclosed herein.
[0140] As used herein, the meanings of "a," "an," and "the" include plural references unless the context clearly indicates a particular type.
[0141] The word "exemplary" as used herein means "serving as an example, instance, or illustration." Any embodiment described herein as "exemplary" is not necessarily to be construed as preferred or superior to other embodiments, and / or is not necessarily to exclude the inclusion of features of other embodiments.
[0142] It should be understood that, for clarity of description, specific features of the invention described in the context of various embodiments may also be implemented in combination in a single embodiment. Conversely, for brevity, various features of the invention described in the context of a single embodiment may also be implemented separately or in any suitable sub-combination, or as appropriate in any other described embodiment of the invention. Specific features described in the context of various embodiments are not considered essential features of those embodiments unless the embodiment is inoperable without those elements.
[0143] The above steps, including some steps, can be performed by software, hardware and / or a combination thereof. These steps and some steps thereof can be performed by computers, computer-type devices, workstations, processors, microprocessors, other electronic search tools, memory and related non-temporary storage devices. The steps and some steps thereof can also be embedded in programmable non-temporary storage media or other computer-usable storage media, wherein the programmable non-temporary storage media are, for example, compact disks (CDs) or other disks including magnetic and optical disks, and are read by machines or the like, and the computer-usable storage media include magnetic, optical, or semiconductor storage or other electronic signal resources.
[0144] The steps (methods) and systems including components have been described herein as exemplary with reference to specific hardware and software. The steps (methods) have been described as exemplary, wherein specific steps and their order may be omitted and / or changed by one of ordinary skill in the art to facilitate implementation of these embodiments without undue experimentation. The description of the steps (methods) and systems is sufficient to enable one of ordinary skill in the art to easily adapt to other hardware and software that may be required in order to implement any embodiment without undue experimentation and using conventional techniques.
[0145] Although the present invention has been described in conjunction with specific embodiments of the present invention, it is apparent that many substitutions, modifications and variations are apparent to those skilled in the art. Therefore, it is intended to encompass all such substitutions, modifications and variations that fall within the spirit and broad scope of the appended claims.
Claims
1. A microfluidic device, characterized in that: The microfluidic device comprises: A substrate, comprising a first side and a second side disposed opposite to each other; a mixing chamber, the mixing chamber being conical and extending into the base plate and to a pedestal and tapering inwardly from the first side to the second side of the base plate, the mixing chamber comprising a protruding element forming a wall of the mixing chamber, the protruding element comprising a plurality of overlapping plates made of a flexible and elastic material to form the wall of the mixing chamber and providing a traction force for mixing substances in the mixing chamber; and A main channel extends from the mixing chamber along the base of the substrate and along at least a portion of the wall of the mixing chamber, wherein the main channel is between the plate forming the wall of the mixing chamber and the base of the substrate.
2. The microfluidic device according to claim 1, wherein: The microfluidic device additionally includes at least one channel extending from the main channel, the at least one channel being configured to align with optics of an apparatus in which the substrate is being viewed.
3. The microfluidic device according to claim 1, wherein: The main channel is C-shaped and conforms to the outer shape of the wall of the mixing chamber.
4. The microfluidic device according to claim 3, characterized in that: The main channel includes an upper wall and a lower wall that are arranged opposite to each other, and an outer wall between the upper wall and the lower wall.
5. The microfluidic device according to claim 4, characterized in that: The main channel makes the outer wall substantially perpendicular to the upper wall and the lower wall which are arranged oppositely.
6. The microfluidic device according to claim 5, characterized in that: The main channel is sized to facilitate capillary action to move liquid through the main channel.
7. The microfluidic device of claim 1, wherein: The first side of the substrate includes a surface, and the mixing chamber extends from the surface into the substrate.
8. The microfluidic device of claim 2, wherein: At least one channel extending from the main channel communicates with the surrounding environment through an openable aperture, such that communication with the surrounding environment causes the at least one channel extending from the main channel to be filled with liquid from the main channel.
